Biphasic Mesothelioma

Biphasic mesothelioma (also called mixed mesothelioma) is a tumor that contains a mixture of two distinct cell types, epithelioid cells (which look more organized and gland-like) and sarcomatoid cells (which look spindle-shaped and disorganized). To be called biphasic, at least 10% of each cell type must be present in the tumor.

Origin

From the Greek "bi" (two) and "phasis" (appearance or phase). The biphasic subtype of mesothelioma was formally recognized in the World Health Organization classification of pleural tumors and remains one of the three core histological subtypes alongside epithelioid and sarcomatoid mesothelioma.

Significance in Asbestos Context

For mesothelioma patients, the biphasic subtype sits between epithelioid (generally better prognosis) and sarcomatoid (generally worse prognosis) in terms of expected response to treatment and survival. The proportion of each component matters: biphasic tumors that are mostly epithelioid often behave more like epithelioid disease, while those dominated by sarcomatoid cells tend to behave more aggressively. Because small biopsies can miss one of the two components, the final subtype is sometimes only confirmed after a larger surgical sample is examined, which can change treatment recommendations and eligibility for surgery or clinical trials. In legal claims, the pathology report's identification of biphasic mesothelioma is part of the medical record that documents the diagnosis and supports the link to asbestos exposure.

Example Sentence

After reviewing the larger surgical specimen, the pathologist reclassified the tumor from epithelioid to biphasic mesothelioma, which prompted the oncology team to revisit the treatment plan.

Related Terms

Mesothelioma, Epithelioid Mesothelioma, Sarcomatoid Mesothelioma, Histological Subtype, Immunohistochemistry, Pathology Report, Biphasic mesothelioma guide

Notes

• Ask your oncologist or pathologist what percentage of epithelioid versus sarcomatoid cells was found. This proportion influences prognosis and treatment options.
• If your diagnosis came from a small needle biopsy, ask whether a second opinion or a larger tissue sample (such as from VATS surgery) would help confirm the subtype, since biphasic tumors are often under-recognized on small samples.
• Request that your pathology slides be reviewed at a mesothelioma specialty center; subtype classification directly affects eligibility for surgery, immunotherapy, and clinical trials.
• Keep copies of all pathology reports and slide reviews. These documents are central to both your medical care and any legal claim related to asbestos exposure.